{"id":1593,"date":"2025-07-25T15:55:22","date_gmt":"2025-07-25T15:55:22","guid":{"rendered":"https:\/\/www.africanews.info\/fr\/?p=1593"},"modified":"2025-07-25T15:55:22","modified_gmt":"2025-07-25T15:55:22","slug":"un-interet-majeur-premier-feu-vert-europeen-pour-un-traitement-ultra-prometteur-contre-le-vih","status":"publish","type":"post","link":"https:\/\/www.africanews.info\/fr\/archives\/1593","title":{"rendered":"Un \u00ab int\u00e9r\u00eat majeur \u00bb : premier feu vert europ\u00e9en pour un traitement ultra-prometteur contre le VIH"},"content":{"rendered":"<div class=\"article-image-slot image-slot-placeholder\" data-is-first=\"true\" data-doc-id=\"cms\/api\/amp\/image\/AA1JhNsV\">\n<div class=\"article-image-slot\">\n<div class=\"article-image-container polished\" data-t=\"{&quot;n&quot;:&quot;OpenModal&quot;,&quot;t&quot;:13,&quot;b&quot;:8,&quot;c.i&quot;:&quot;AA1Ji3cj&quot;,&quot;c.l&quot;:false,&quot;c.t&quot;:13,&quot;c.v&quot;:&quot;health&quot;,&quot;c.c&quot;:&quot;health-news&quot;,&quot;c.b&quot;:&quot;Le Parisien&quot;,&quot;c.bi&quot;:&quot;BB5KI1f&quot;,&quot;c.tv&quot;:&quot;health&quot;,&quot;c.tc&quot;:&quot;diseases-and-conditions&quot;,&quot;c.hl&quot;:&quot;Un \u00ab int\u00e9r\u00eat majeur \u00bb : premier feu vert europ\u00e9en pour un traitement ultra-prometteur contre le VIH&quot;}\" data-test-id=\"AA1JhNsV\">\n<div><\/div>\n<p><button class=\"article-image-height-wrapper expandable article-image-height-wrapper-new\" data-customhandled=\"true\" data-t=\"{&quot;n&quot;:&quot;OpenModalButton&quot;,&quot;a&quot;:&quot;click&quot;,&quot;b&quot;:1,&quot;c.i&quot;:&quot;AA1Ji3cj&quot;,&quot;c.l&quot;:false,&quot;c.t&quot;:13,&quot;c.v&quot;:&quot;health&quot;,&quot;c.c&quot;:&quot;health-news&quot;,&quot;c.b&quot;:&quot;Le Parisien&quot;,&quot;c.bi&quot;:&quot;BB5KI1f&quot;,&quot;c.tv&quot;:&quot;health&quot;,&quot;c.tc&quot;:&quot;diseases-and-conditions&quot;,&quot;c.hl&quot;:&quot;Un \u00ab int\u00e9r\u00eat majeur \u00bb : premier feu vert europ\u00e9en pour un traitement ultra-prometteur contre le VIH&quot;}\"><img decoding=\"async\" class=\"article-image article-image-ux-impr article-image-new expandable\" title=\"Le lenacapavir est un traitement pr\u00e9ventif, qui agit en bloquant la multiplication du VIH dans nos cellules. Sipa\/AP\/Nardus Engelbrecht\" src=\"https:\/\/img-s-msn-com.akamaized.net\/tenant\/amp\/entityid\/AA1JhNsV.img?w=768&amp;h=432&amp;m=6\" alt=\"Le lenacapavir est un traitement pr\u00e9ventif, qui agit en bloquant la multiplication du VIH dans nos cellules. Sipa\/AP\/Nardus Engelbrecht\" \/><\/button><\/p>\n<div class=\"image-caption-container image-caption-container-ux-impr articlewc-image-caption-container\"><span class=\"image-caption\">Le lenacapavir est un traitement pr\u00e9ventif, qui agit en bloquant la multiplication du VIH dans nos cellules. Sipa\/AP\/Nardus Engelbrecht<\/span><span class=\"image-attribution image-attribution-ux-impr\">\u00a9\u00a0Nardus Engelbrecht\/AP\/SIPA<\/span><\/div>\n<\/div>\n<\/div>\n<\/div>\n<p data-t=\"{&quot;n&quot;:&quot;blueLinks&quot;,&quot;t&quot;:13,&quot;a&quot;:&quot;click&quot;,&quot;b&quot;:76}\">Le Pr Yazdan Yazdanpanah y voit \u00ab\u00a0<a title=\"https:\/\/www.leparisien.fr\/societe\/sante\/cest-un-game-changer-contre-le-sida-un-medicament-ultra-prometteur-autorise-aux-etats-unis-19-06-2025-FDJFSSI4GZEBBPXTCFYXRD2Z5I.php\" href=\"https:\/\/www.leparisien.fr\/societe\/sante\/cest-un-game-changer-contre-le-sida-un-medicament-ultra-prometteur-autorise-aux-etats-unis-19-06-2025-FDJFSSI4GZEBBPXTCFYXRD2Z5I.php\" target=\"_blank\" rel=\"noopener noreferrer\" data-t=\"{&quot;n&quot;:&quot;destination&quot;,&quot;t&quot;:13,&quot;a&quot;:&quot;click&quot;,&quot;b&quot;:1,&quot;c.t&quot;:7}\">un game changer<\/a>, sans doute le plus important depuis l\u2019arriv\u00e9e des trith\u00e9rapies dans les ann\u00e9es 2000 \u00bb. Et ce nouveau traitement ultra-prometteur contre le VIH, appel\u00e9 Yeytuo (mol\u00e9cule lenacapavir), a re\u00e7u\u00a0<a title=\"https:\/\/www.ema.europa.eu\/en\/news\/new-injection-easier-prevention-hiv-infection-eu-worldwide\" href=\"https:\/\/www.ema.europa.eu\/en\/news\/new-injection-easier-prevention-hiv-infection-eu-worldwide\" target=\"_blank\" rel=\"noopener noreferrer\" data-t=\"{&quot;n&quot;:&quot;destination&quot;,&quot;t&quot;:13,&quot;a&quot;:&quot;click&quot;,&quot;b&quot;:1,&quot;c.t&quot;:7}\">un premier feu vert en Europe ce vendredi<\/a>.<\/p>\n<div class=\"intra-article-module\" data-t=\"{&quot;n&quot;:&quot;intraArticle&quot;,&quot;t&quot;:13}\">\n<div class=\"articlePageIntraArticleFullWidth ad-slot-placeholder left-image-intra-ad full-bleed-image-intra-ad\" data-ad-index=\"0\">\n<div class=\"intra-article-ad-full left-image-intra-ad full-bleed-image-intra-ad\">\n<div id=\"msn4856e745c95048659806\" class=\"full-bleed-image-intra-ad\">\n<div class=\"content\">\n<div class=\"hide-story-wrapper\">\n<div id=\"hide-story\" class=\"hide-story\"><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p data-t=\"{&quot;n&quot;:&quot;blueLinks&quot;,&quot;t&quot;:13,&quot;a&quot;:&quot;click&quot;,&quot;b&quot;:76}\">L\u2019Agence europ\u00e9enne des m\u00e9dicaments (EMA) se prononce en ce sens apr\u00e8s avoir examin\u00e9 toutes les donn\u00e9es selon une proc\u00e9dure acc\u00e9l\u00e9r\u00e9e, en raison d\u2019\u00ab un int\u00e9r\u00eat majeur pour la sant\u00e9 publique \u00bb.<\/p>\n<p data-t=\"{&quot;n&quot;:&quot;blueLinks&quot;,&quot;t&quot;:13,&quot;a&quot;:&quot;click&quot;,&quot;b&quot;:76}\">Ce traitement antiviral est pr\u00e9ventif, ce qu\u2019on appelle PrEP (prophylaxie pr\u00e9-exposition). Il agit en se fixant sur la partie du virus qui entoure son g\u00e9nome, bloquant ainsi la multiplication du VIH dans nos cellules. Associ\u00e9 \u00e0 des pratiques sexuelles \u00e0 moindre risque, il\u00a0<a title=\"https:\/\/www.leparisien.fr\/societe\/sante\/quel-est-ce-traitement-preventif-tres-prometteur-contre-le-vih-que-viennent-dapprouver-les-etats-unis-18-06-2025-APYYOMTRGZDK7N2225V4PPYOQM.php\" href=\"https:\/\/www.leparisien.fr\/societe\/sante\/quel-est-ce-traitement-preventif-tres-prometteur-contre-le-vih-que-viennent-dapprouver-les-etats-unis-18-06-2025-APYYOMTRGZDK7N2225V4PPYOQM.php\" target=\"_blank\" rel=\"noopener noreferrer\" data-t=\"{&quot;n&quot;:&quot;destination&quot;,&quot;t&quot;:13,&quot;a&quot;:&quot;click&quot;,&quot;b&quot;:1,&quot;c.t&quot;:7}\">permet de r\u00e9duire le risque d\u2019infection et donc de sida<\/a>. Les \u00e9tudes disponibles sugg\u00e8rent une tr\u00e8s forte efficacit\u00e9, selon le Pr Yazdanpanah, directeur de l\u2019Agence nationale de recherches sur le sida et les h\u00e9patites virales maladies infectieuses \u00e9mergentes.<\/p>\n<h1>\u00ab On souhaite qu\u2019il soit pris en charge \u00e0 100 % \u00bb<\/h1>\n<p data-t=\"{&quot;n&quot;:&quot;blueLinks&quot;,&quot;t&quot;:13,&quot;a&quot;:&quot;click&quot;,&quot;b&quot;:76}\">Par ailleurs, par rapport aux PrEP qui existent d\u00e9j\u00e0, le lenacapavir ne n\u00e9cessite qu\u2019une injection deux fois par an. De quoi \u00ab faciliter l\u2019adoption de ce traitement \u00bb, estime l\u2019EMA. \u00ab On suit les PrEP injectables depuis longtemps, et on en attend beaucoup. En plus d\u2019\u00eatre plus efficaces, elles pourraient b\u00e9n\u00e9ficier aux personnes qui n\u2019ont pas acc\u00e8s \u00e0 celle en comprim\u00e9s \u00bb, nous indiquait en juin Fabrice Pilorg\u00e9, directeur du plaidoyer de l\u2019association AIDES.<\/p>\n<div class=\"intra-article-module\" data-t=\"{&quot;n&quot;:&quot;intraArticle&quot;,&quot;t&quot;:13}\">\n<div class=\"articlePageIntraArticleFullWidth ad-slot-placeholder left-image-intra-ad full-bleed-image-intra-ad\" data-ad-index=\"1\">\n<div class=\"intra-article-ad-full left-image-intra-ad full-bleed-image-intra-ad\">\n<div id=\"adnxs-087b92647b3f4dd3b381\" class=\"full-bleed-image-intra-ad\">\n<div class=\"content\">\n<div class=\"text\">\n<div id=\"abstract\" class=\"abstract\">\n<div class=\"call-to-action\">Autoris\u00e9 aux \u00c9tats-Unis mi-juin et d\u00e9sormais en Europe, le lenacapavir ne sera pas tout de suite disponible en France. La Haute Autorit\u00e9 de sant\u00e9 doit encore se prononcer. Et si elle donne un avis favorable au remboursement, des n\u00e9gociations d\u00e9buteront entre les autorit\u00e9s sanitaires et le laboratoire pour s\u2019accorder sur un prix.<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p data-t=\"{&quot;n&quot;:&quot;blueLinks&quot;,&quot;t&quot;:13,&quot;a&quot;:&quot;click&quot;,&quot;b&quot;:76}\">Celles-ci s\u2019annoncent complexes, car\u00a0<a title=\"https:\/\/www.leparisien.fr\/societe\/sante\/sida-un-traitement-prometteur-1-000-fois-moins-cher-en-version-generique-selon-des-chercheurs-23-07-2024-NXRQBHDZXZECPNCU3Q7HPMYN3A.php\" href=\"https:\/\/www.leparisien.fr\/societe\/sante\/sida-un-traitement-prometteur-1-000-fois-moins-cher-en-version-generique-selon-des-chercheurs-23-07-2024-NXRQBHDZXZECPNCU3Q7HPMYN3A.php\" target=\"_blank\" rel=\"noopener noreferrer\" data-t=\"{&quot;n&quot;:&quot;destination&quot;,&quot;t&quot;:13,&quot;a&quot;:&quot;click&quot;,&quot;b&quot;:1,&quot;c.t&quot;:7}\">cette injection co\u00fbte aujourd\u2019hui tr\u00e8s cher<\/a>\u00a0(pr\u00e8s de 30 000 dollars par patient et par an aux \u00c9tats-Unis). \u00ab On souhaite que ce traitement soit pris en charge \u00e0 100 %, mais on ne l\u2019esp\u00e8re pas avant 2027, le temps que toutes les \u00e9tapes soient franchies \u00bb, anticipe Fabrice Pilorg\u00e9.<\/p>\n<div class=\"intra-article-module-bottom-slot\" data-t=\"{&quot;n&quot;:&quot;intraArticle&quot;,&quot;t&quot;:13}\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Le lenacapavir est un traitement pr\u00e9ventif, qui agit en bloquant la multiplication du VIH dans nos cellules. Sipa\/AP\/Nardus Engelbrecht\u00a9\u00a0Nardus Engelbrecht\/AP\/SIPA&hellip;<\/p>\n","protected":false},"author":1,"featured_media":1594,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[],"class_list":["post-1593","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-la-une"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Un \u00ab int\u00e9r\u00eat majeur \u00bb : premier feu vert europ\u00e9en pour un traitement ultra-prometteur contre le VIH - Africanews | info<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.africanews.info\/fr\/archives\/1593\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Un \u00ab int\u00e9r\u00eat majeur \u00bb : premier feu vert europ\u00e9en pour un traitement ultra-prometteur contre le VIH - Africanews | info\" \/>\n<meta property=\"og:description\" content=\"Le lenacapavir est un traitement pr\u00e9ventif, qui agit en bloquant la multiplication du VIH dans nos cellules. Sipa\/AP\/Nardus Engelbrecht\u00a9\u00a0Nardus Engelbrecht\/AP\/SIPA&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.africanews.info\/fr\/archives\/1593\" \/>\n<meta property=\"og:site_name\" content=\"Africanews | info\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-25T15:55:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.africanews.info\/fr\/wp-content\/uploads\/2025\/07\/AA1JhNsV.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"768\" \/>\n\t<meta property=\"og:image:height\" content=\"432\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"africanews123C\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"africanews123C\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.africanews.info\/fr\/archives\/1593#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.africanews.info\/fr\/archives\/1593\"},\"author\":{\"name\":\"africanews123C\",\"@id\":\"https:\/\/www.africanews.info\/fr\/#\/schema\/person\/5024a6b2bd0d87362c32345fe8085259\"},\"headline\":\"Un \u00ab int\u00e9r\u00eat majeur \u00bb : premier feu vert europ\u00e9en pour un traitement ultra-prometteur contre le VIH\",\"datePublished\":\"2025-07-25T15:55:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.africanews.info\/fr\/archives\/1593\"},\"wordCount\":421,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.africanews.info\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.africanews.info\/fr\/archives\/1593#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.africanews.info\/fr\/wp-content\/uploads\/2025\/07\/AA1JhNsV.jpeg\",\"articleSection\":[\"La une\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.africanews.info\/fr\/archives\/1593#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.africanews.info\/fr\/archives\/1593\",\"url\":\"https:\/\/www.africanews.info\/fr\/archives\/1593\",\"name\":\"Un \u00ab int\u00e9r\u00eat majeur \u00bb : premier feu vert europ\u00e9en pour un traitement ultra-prometteur contre le VIH - Africanews | info\",\"isPartOf\":{\"@id\":\"https:\/\/www.africanews.info\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.africanews.info\/fr\/archives\/1593#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.africanews.info\/fr\/archives\/1593#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.africanews.info\/fr\/wp-content\/uploads\/2025\/07\/AA1JhNsV.jpeg\",\"datePublished\":\"2025-07-25T15:55:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.africanews.info\/fr\/archives\/1593#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.africanews.info\/fr\/archives\/1593\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.africanews.info\/fr\/archives\/1593#primaryimage\",\"url\":\"https:\/\/www.africanews.info\/fr\/wp-content\/uploads\/2025\/07\/AA1JhNsV.jpeg\",\"contentUrl\":\"https:\/\/www.africanews.info\/fr\/wp-content\/uploads\/2025\/07\/AA1JhNsV.jpeg\",\"width\":768,\"height\":432},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.africanews.info\/fr\/archives\/1593#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.africanews.info\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Un \u00ab int\u00e9r\u00eat majeur \u00bb : premier feu vert europ\u00e9en pour un traitement ultra-prometteur contre le VIH\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.africanews.info\/fr\/#website\",\"url\":\"https:\/\/www.africanews.info\/fr\/\",\"name\":\"Africanews | info\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.africanews.info\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.africanews.info\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.africanews.info\/fr\/#organization\",\"name\":\"Africanews | info\",\"url\":\"https:\/\/www.africanews.info\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.africanews.info\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.africanews.info\/fr\/wp-content\/uploads\/2025\/04\/cropped-Untitled-5.png\",\"contentUrl\":\"https:\/\/www.africanews.info\/fr\/wp-content\/uploads\/2025\/04\/cropped-Untitled-5.png\",\"width\":632,\"height\":245,\"caption\":\"Africanews | info\"},\"image\":{\"@id\":\"https:\/\/www.africanews.info\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.africanews.info\/fr\/#\/schema\/person\/5024a6b2bd0d87362c32345fe8085259\",\"name\":\"africanews123C\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.africanews.info\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/458600830c8a7b0adfc1866b9a30327d5fc11a24cfcf256ad886cd03b58f74a9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/458600830c8a7b0adfc1866b9a30327d5fc11a24cfcf256ad886cd03b58f74a9?s=96&d=mm&r=g\",\"caption\":\"africanews123C\"},\"sameAs\":[\"https:\/\/www.africanews.info\/fr\"],\"url\":\"https:\/\/www.africanews.info\/fr\/archives\/author\/africanews123c\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Un \u00ab int\u00e9r\u00eat majeur \u00bb : premier feu vert europ\u00e9en pour un traitement ultra-prometteur contre le VIH - Africanews | info","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.africanews.info\/fr\/archives\/1593","og_locale":"fr_FR","og_type":"article","og_title":"Un \u00ab int\u00e9r\u00eat majeur \u00bb : premier feu vert europ\u00e9en pour un traitement ultra-prometteur contre le VIH - Africanews | info","og_description":"Le lenacapavir est un traitement pr\u00e9ventif, qui agit en bloquant la multiplication du VIH dans nos cellules. Sipa\/AP\/Nardus Engelbrecht\u00a9\u00a0Nardus Engelbrecht\/AP\/SIPA&hellip;","og_url":"https:\/\/www.africanews.info\/fr\/archives\/1593","og_site_name":"Africanews | info","article_published_time":"2025-07-25T15:55:22+00:00","og_image":[{"width":768,"height":432,"url":"https:\/\/www.africanews.info\/fr\/wp-content\/uploads\/2025\/07\/AA1JhNsV.jpeg","type":"image\/jpeg"}],"author":"africanews123C","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"africanews123C","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.africanews.info\/fr\/archives\/1593#article","isPartOf":{"@id":"https:\/\/www.africanews.info\/fr\/archives\/1593"},"author":{"name":"africanews123C","@id":"https:\/\/www.africanews.info\/fr\/#\/schema\/person\/5024a6b2bd0d87362c32345fe8085259"},"headline":"Un \u00ab int\u00e9r\u00eat majeur \u00bb : premier feu vert europ\u00e9en pour un traitement ultra-prometteur contre le VIH","datePublished":"2025-07-25T15:55:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.africanews.info\/fr\/archives\/1593"},"wordCount":421,"commentCount":0,"publisher":{"@id":"https:\/\/www.africanews.info\/fr\/#organization"},"image":{"@id":"https:\/\/www.africanews.info\/fr\/archives\/1593#primaryimage"},"thumbnailUrl":"https:\/\/www.africanews.info\/fr\/wp-content\/uploads\/2025\/07\/AA1JhNsV.jpeg","articleSection":["La une"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.africanews.info\/fr\/archives\/1593#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.africanews.info\/fr\/archives\/1593","url":"https:\/\/www.africanews.info\/fr\/archives\/1593","name":"Un \u00ab int\u00e9r\u00eat majeur \u00bb : premier feu vert europ\u00e9en pour un traitement ultra-prometteur contre le VIH - Africanews | info","isPartOf":{"@id":"https:\/\/www.africanews.info\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.africanews.info\/fr\/archives\/1593#primaryimage"},"image":{"@id":"https:\/\/www.africanews.info\/fr\/archives\/1593#primaryimage"},"thumbnailUrl":"https:\/\/www.africanews.info\/fr\/wp-content\/uploads\/2025\/07\/AA1JhNsV.jpeg","datePublished":"2025-07-25T15:55:22+00:00","breadcrumb":{"@id":"https:\/\/www.africanews.info\/fr\/archives\/1593#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.africanews.info\/fr\/archives\/1593"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.africanews.info\/fr\/archives\/1593#primaryimage","url":"https:\/\/www.africanews.info\/fr\/wp-content\/uploads\/2025\/07\/AA1JhNsV.jpeg","contentUrl":"https:\/\/www.africanews.info\/fr\/wp-content\/uploads\/2025\/07\/AA1JhNsV.jpeg","width":768,"height":432},{"@type":"BreadcrumbList","@id":"https:\/\/www.africanews.info\/fr\/archives\/1593#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.africanews.info\/fr\/"},{"@type":"ListItem","position":2,"name":"Un \u00ab int\u00e9r\u00eat majeur \u00bb : premier feu vert europ\u00e9en pour un traitement ultra-prometteur contre le VIH"}]},{"@type":"WebSite","@id":"https:\/\/www.africanews.info\/fr\/#website","url":"https:\/\/www.africanews.info\/fr\/","name":"Africanews | info","description":"","publisher":{"@id":"https:\/\/www.africanews.info\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.africanews.info\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.africanews.info\/fr\/#organization","name":"Africanews | info","url":"https:\/\/www.africanews.info\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.africanews.info\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.africanews.info\/fr\/wp-content\/uploads\/2025\/04\/cropped-Untitled-5.png","contentUrl":"https:\/\/www.africanews.info\/fr\/wp-content\/uploads\/2025\/04\/cropped-Untitled-5.png","width":632,"height":245,"caption":"Africanews | info"},"image":{"@id":"https:\/\/www.africanews.info\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.africanews.info\/fr\/#\/schema\/person\/5024a6b2bd0d87362c32345fe8085259","name":"africanews123C","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.africanews.info\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/458600830c8a7b0adfc1866b9a30327d5fc11a24cfcf256ad886cd03b58f74a9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/458600830c8a7b0adfc1866b9a30327d5fc11a24cfcf256ad886cd03b58f74a9?s=96&d=mm&r=g","caption":"africanews123C"},"sameAs":["https:\/\/www.africanews.info\/fr"],"url":"https:\/\/www.africanews.info\/fr\/archives\/author\/africanews123c"}]}},"_links":{"self":[{"href":"https:\/\/www.africanews.info\/fr\/wp-json\/wp\/v2\/posts\/1593","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.africanews.info\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.africanews.info\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.africanews.info\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.africanews.info\/fr\/wp-json\/wp\/v2\/comments?post=1593"}],"version-history":[{"count":1,"href":"https:\/\/www.africanews.info\/fr\/wp-json\/wp\/v2\/posts\/1593\/revisions"}],"predecessor-version":[{"id":1595,"href":"https:\/\/www.africanews.info\/fr\/wp-json\/wp\/v2\/posts\/1593\/revisions\/1595"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.africanews.info\/fr\/wp-json\/wp\/v2\/media\/1594"}],"wp:attachment":[{"href":"https:\/\/www.africanews.info\/fr\/wp-json\/wp\/v2\/media?parent=1593"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.africanews.info\/fr\/wp-json\/wp\/v2\/categories?post=1593"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.africanews.info\/fr\/wp-json\/wp\/v2\/tags?post=1593"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}